ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Wilkinson T 

PROVIDER: S-EPMC7393340 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature